Sharon Plon, MD, PhD – Research Interests: Genetic basis of inherited susceptibility to cancer. Clinical Specialties: cancer genetics syndromes; breast ovarian cancer susceptibility; von Hippel Lindau Syndrome; neurofibromatosis; retinoblastoma and familial adenomatous polyposis.
Donald “Will” Parsons, MD, PhD – Research Interests: Clinical application of genomic technologies in pediatric cancer care; identification and characterization of cancer-causing mutations in pediatric tumors. Clinical Specialties: brain tumors, liver tumors, spinal cord tumors.
Alison Bertuch, MD, PhD – Research Interests: telomere structure and function; telomere dysfunction in the development of bone marrow failure in children. Clinical Specialties: oncology, osterosarcoma and bone marrow failure.
Ricardo Flores, MD – Research Interests: tumor-targeted approach to identify metastatic biomarkers in osteosarcoma tumor cells. Clinical Specialties: CNS Langerhan’s cell histiocytosis
M. Monica Gramatges, MD, PhD– Research Interests: leukemia, cancer genetics and survivorship. Clinical Specialties: leukemia; lymphoma; genetic risks for development of acute myeloid leukemia; chemotherapy-related toxicity; survivorship
Chris Tsz-Kwong Man, PhD – Research Interests: molecular classification of osteosarcoma using expression and proteomic profiling; transcription network and function analysis of cancer signatures and cancer bioinformatics
Debananda Pati, PhD – Research Interests: identification of proteins that coordinate aneuploidy, cell division, and apoptosis; chromosomal cohesion and separation in aneuploidy and tumorigenesis
Pulivarthi Rao, PhD – Research Interests: genetic basis of deregulation of cellular proliferation; differentiation associated with malignant transformation
Pavel Sumazin, PhD – Research Interests: interpretation of molecular profiles of human tumors to inform cancer diagnostics and therapeutics
Lisa Wang, MD – Research Interests: molecular basis of osteosarcoma, RECQL4, Rothmund-Thomson syndrome. Clinical Specialties: sarcomas, particularly bone sarcomas (osteosarcoma, Ewing’s sarcoma)
David Wheeler, PhD — As the director of cancer genomics and assistant director of the Baylor College of Medicine Human Genome Sequencing Center, Dr. Wheeler leads the development of methods for discovery of genome variation in human and animal populations using DNA sequencing technologies with the goal of relating polymorphism to human disease.